Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent Plasma in Covid-19
NCT04600440Unknown
- Sponsor
- Skåne University Hospital
- Start
- Apr 2020
- Primary completion
- Dec 2021
- Modality
- Biologic
- Countries
- 1
01
Overview
Randomised, open-label trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Skåne University Hospital. Primary endpoint: Number of days in need of oxygen at 28 days. Status: unknown.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04600440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04600440.